Apotex acquires specialty drugmaker Searchlight in expansion move

03 Apr 2024
www.fiercepharma.com
Acquisition
Apotex acquires specialty drugmaker Searchlight in expansion move
Preview
Source: FiercePharma
Canadian generics maker Apotex is set to acquire Searchlight Pharma for an undisclosed price as part of a move to expand its offerings and operations.
Apotex, a Toronto-based generics maker, inked a deal to acquire fellow Canadian pharma company Searchlight Pharma.
The acquisition, which is expected to be completed by mid-year, is expected to boost Apotex’s expansion in the specialty branded pharma market with the addition of more than 60 products from Searchlight, the company said in an April 2 press release.
The companies didn't reveal the price of the buyout.
Searchlight's home office will remain in Montreal, and Apotex plans to expand its operations in the province of Quebec.
“This acquisition is a strategic complement to Apotex's leading market position in generic and biosimilar pharmaceuticals, in alignment with our ongoing focus to expand into the high-value, innovative branded pharmaceuticals sector,” Allan Oberman, Apotex president and CEO, said in the release.
Apotex was most recently in the news when it and two of its generics peers agreed in January in a Pennsylvania federal court to settle a price-fixing case that dated back to 2017.
The case, which also involved Heritage Pharmaceuticals and Breckenridge Pharmaceutical, involved claims of price fixing related to drugs they sold to direct purchasers.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.